There are "obvious flaws" on Abbisko’s pipeline and targets, leading to limited investment value and gloomy commercialization outlook. So, share buybacks and LAV's increase in holdings may be useless.
What is covered in the Full Insight:
Company Overview
Company's Product Pipeline
Targeted Indication Backgrounds
Challenges in Market Potential
Analyst's Viewpoint
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.